Back to resultsFlupenthixol Decanoate in Methamphetamine Smoking - 1
Primary Purpose
Substance-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Flupenthixol
Sponsored by
About this trial
This is an interventional treatment trial for Substance-Related Disorders focused on measuring methamphetamine dependence
Eligibility Criteria
Please contact site for information.
Sites / Locations
- Friends Research Institute
Outcomes
Primary Outcome Measures
Methamphetamine use
Secondary Outcome Measures
Full Information
NCT ID
NCT00000241
First Posted
September 20, 1999
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Friends Research Institute, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT00000241
Brief Title
Flupenthixol Decanoate in Methamphetamine Smoking - 1
Official Title
Flupenthixol Decanoate in Methamphetamine Smoking
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
February 1994 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
May 1996 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Friends Research Institute, Inc.
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance-Related Disorders
Keywords
methamphetamine dependence
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
58 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Flupenthixol
Primary Outcome Measure Information:
Title
Methamphetamine use
10. Eligibility
Sex
All
Minimum Age & Unit of Time
22 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frank Gawin, M.D.
Organizational Affiliation
Friends Research Institute, Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Friends Research Institute
City
Los Angeles
State/Province
California
ZIP/Postal Code
90025
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Flupenthixol Decanoate in Methamphetamine Smoking - 1
We'll reach out to this number within 24 hrs